IP Library Granted Patent US 6,875,597
Granted Patent B2
US 6,875,597 · App. 10/798,414 · Granted Apr 5, 2005

Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,875,597
App. No.
10/798,414
Granted
Apr 5, 2005
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the drug-metabolizing enzyme peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the drug-metabolizing enzyme peptides, and methods of identifying modulators of the drug-metabolizing enzyme peptides.

Claims (20)

1. An isolated nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence that encodes a protein comprising the amino acid sequence of SEQ ID NO:2;

(b) a nucleic acid molecule consisting of the nucleic acid sequence of SEQ ID No: 1;

(c) a nucleic acid molecule consisting of the nucleic acid sequence of SEQ ID No: 3; and

(d) a nucleotide sequence that is completely complementary to a nucleotide sequence of (a)-(c).

2. A nucleic acid vector comprising a nucleic acid molecule of claim 1 .

3. A host cell containing the vector of claim 2 .

4. A process for producing a polypeptide comprising culturing the host cell of claim 3 under conditions sufficient for the production of said polypeptide, and recovering the peptide from the host cell culture.

5. An isolated polynucleotide comprising a nucleotide sequence set forth in SEQ ID NO:1.

6. An isolated polynucleotide comprising a nucleotide sequence set forth in SEQ ID NO:3.

7. A vector according to claim 2 , wherein said vector is selected from the group consisting of a plasmid, virus, and bacteriophage.

8. A vector according to claim 2 , wherein said isolated nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that the protein of SEQ ID NO: 2 may be expressed by a cell transformed with said vector.

9. A vector according to claim 8 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

10. An isolated nucleic acid molecule encoding a human drug-metabolizing enzyme peptide, said nucleic acid molecule sharing at least 95 percent homology with a nucleic acid molecule shown in SEQ ID NOS:1 or 3.

11. A nucleic acid vector comprising a nucleic acid molecule of claim 10 .

12. A host cell containing the vector of claim 11 .

13. A process for producing a polypeptide comprising culturing the host cell of claim 12 under conditions sufficient for the production of said polypeptide, and recovering the peptide from the host cell culture.

14. A vector according to claim 11 , wherein said vector is selected from the group consisting of a plasmid, virus, and bacteriophage.

15. A vector according to claim 11 , wherein said isolated nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that the protein of SEQ ID NO: 2 may be expressed by a cell transformed with said vector.

16. A vector according to claim 15 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →